SCHEMBL27359779

SCHEMBL27359779

Cn1nc2cccc(Cl)c2c1C#N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSMB8 P28062 4/20 0.46
▸ PSMB5 P28074 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.36
▸ PRMT5 O14744 1/20 0.36
▸ LMNA P02545 1/20 0.35
▸ PARP1 P09874 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ MAOB P27338 1/20 0.34
▸ PTPN11 Q06124 1/20 0.33
▸ GRM5 P41594 1/20 0.33
▸ PDE4D Q08499 1/20 0.32
▸ PDE7A Q13946 1/20 0.32
▸ PDE3A Q14432 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27359621 0.81 PDE10A (0.37) PSMB8KDM4ELMNAPARP1GRM5
SCHEMBL27359783 0.80 PTPN11 (0.39) PSMB8LMNAHTTPTPN11GRM5
SCHEMBL27359770 0.80 PDE10A (0.38) PSMB8LMNAPARP1MAOBGRM5
SCHEMBL27359788 0.80 PDE10A (0.38) PSMB8LMNAGRM5
SCHEMBL28902124 0.78 PTPN11 (0.34) PSMB8LMNAHTTPTPN11
SCHEMBL30474592 0.77 PRMT5 (0.41) PSMB8PRMT5LMNAPARP1HTT
SCHEMBL13106159 0.75 PARP1 (0.41) PSMB8PRMT5PARP1MAOB
SCHEMBL23663596 0.74 PTPN11 (0.38) LMNAHTTPTPN11L3MBTL1
SCHEMBL29802781 0.73 PTPN11 (0.38) LMNAHTTPTPN11
SCHEMBL28622442 0.73 PTPN11 (0.38) LMNAHTTPTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114981268-B Pyrimidine-4 (3H) -ketone heterocyclic compound, preparation method and application thereof in medicine 北京诺诚健华医药科技有限公司 2025-01-28 — — CN disclosed
WO-2024026536-A1 ANTIVIRAL COMPOUNDS AND USES THEREOF GRIFFITH UNIVERSITY (AU) 2024-02-08 — — WO disclosed
Send feedback